Horizon Therapeutics PLC Price Chart
Horizon Therapeutics PLC HPR.HA Financial and Trading Overview
| Horizon Therapeutics PLC stock price | 109.2 EUR |
| Previous Close | 91.8 EUR |
| Open | 91.4 EUR |
| Bid | 91.4 EUR x N/A |
| Ask | 93.6 EUR x N/A |
| Day's Range | 91.4 - 91.4 EUR |
| 52 Week Range | 58.44 - 108.02 EUR |
| Volume | 100 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
HPR.HA Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Horizon Therapeutics PLC Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 108.02 EUR |
| 52 Week Low | 58.44 EUR |
| 50-Day Moving Average | 96.64 EUR |
| 200-Day Moving Average | 88.35 EUR |
HPR.HA Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Horizon Therapeutics PLC Stock
What is a current HPR.HA stock price?
Horizon Therapeutics PLC HPR.HA stock price today per share is 109.2 EUR.
How to purchase Horizon Therapeutics PLC stock?
You can buy HPR.HA shares on the Hanover exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Horizon Therapeutics PLC?
The stock symbol or ticker of Horizon Therapeutics PLC is HPR.HA.
How many shares does Horizon Therapeutics PLC have in circulation?
The max supply of Horizon Therapeutics PLC shares is 0.
What is Horizon Therapeutics PLC Price to Earnings Ratio (PE Ratio)?
Horizon Therapeutics PLC PE Ratio is 0.00000000 now.
What was Horizon Therapeutics PLC earnings per share over the trailing 12 months (TTM)?
Horizon Therapeutics PLC EPS is 0 EUR over the trailing 12 months.